Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life

Journal of Clinical Oncology

Volumn 25, Issue 34, 2007, Pages 5403-5409

  Buijs, Ciska ^a   Rodenhuis, Sjoerd ^a   Seynaeve, Caroline M ^a   Van Hoesel, Quirinus G C M ^a   Van Der Wall, Elsken ^a   Smit, Wim J M ^a   Nooij, Marianne A ^a   Voest, Emile ^a   Hupperets, Pierre ^a   TenVergert, Els M ^a   Van Tinteren, Harm ^a   Willemse, Pax H B ^a   Mourits, Marian J E ^a   Aaronson, Neil K ^a   Post, Wendy J ^a   De Vries, Elisabeth G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; TAMOXIFEN; THIOTEPA;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; LONGITUDINAL STUDIES; MENOPAUSE; MIDDLE AGED; NEOPLASM STAGING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; TAMOXIFEN; THIOTEPA; TRANSPLANTATION, AUTOLOGOUS;

EID: 36849049669     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.2813     Document Type: Article

References (27)

1. Farquhar CM, Marjoribanks J, Lethaby A, et al: High dose chemotherapy for poor prognosis breast cancer: Systematic review and meta-analysis. Cancer Treat Rev 33:325-337, 2007
2. Carlson LE, Koski T, Gluck S: Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer. Bone Marrow Transplant 27:989-998, 2001
3. McQuellon RP, Craven B, Russell GB, et al: Quality of life in breast cancer patients before and after autologous bone marrow transplantation. Bone Marrow Transplant 18:579-584, 1996
4. Winer EP, Lindley C, Hardee M, et al: Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support. Psychooncology 8:167-176, 1999
5. Hann DM, Jacobsen PB, Martin SC, et al: Quality of life following bone marrow transplantation for breast cancer: A comparative study. Bone Marrow Transplant 19:257-264, 1997
6. Bottomley A, Therasse P: Quality of life in patients undergoing systemic therapy for advanced breast cancer. Lancet Oncol 3:620-628, 2002
7. Brandberg Y, Michelson H, Nilsson B, et al: Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401. J Clin Oncol 21:3659-3664, 2003
8. Ganz PA, Desmond KA, Leedham B, et al: Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. J Natl Cancer Inst 94:39-49, 2002
9. Conner-Spady BL, Cumming C, Nabholtz JM, et al: A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation. Bone Marrow Transplant 36:251-259, 2005
10. Peppercorn J, Herndon J, Kornblith AB, et al: Quality of life among patients with stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy. Cancer 104:1580-1589, 2005
11. Rodenhuis S, Bontenbal M, Beex LV, et al: High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. N Engl J Med 349:7-16, 2003
12. Rodenhuis S, Bontenbal M, van Hoesel QG, et al: Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer. Ann Oncol 17:588-596, 2006
13. Ware JE, Snow KK, Kosinski M, et al: SF-36 Health Survey, Manual and Interpretation Guide. Boston, MA, The Health Institute, New England Medical Center, 1993
14. Aaronson NK, Muller M, Cohen PD, et al: Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055-1068, 1998
15. Fallowfield LJ: Assessment of quality of life in breast cancer. Acta Oncol 34:689-694, 1995
16. Rasbash J, Steele P, Browne W, et al: A User's Guide to MLwiN. London, United Kingdom, Institute of Education, 2000
17. Gueorguieva R, Krystal JH: Move over ANOVA: Progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 61:310-317, 2004
18. Cohen J: A power primer. Psychol Bull 112: 155-159, 1992
19. Partridge AH, Winer EP: Quality of life issues among women undergoing high-dose chemotherapy for breast cancer. Breast Dis 14:41-50, 2001
20. Peters WP, Ross M, Vredenburgh JJ, et al: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132-1143, 1993
21. Bower JE: Prevalence and causes of fatigue after cancer treatment: The next generation of research. J Clin Oncol 23:8280-8281, 2005
22. Dorval M, Maunsell E, Deschenes L, et al: Long-term quality of life after breast cancer: Comparison of 8-year survivors with population controls. J Clin Oncol 16:487-494, 1998
23. Stead ML: Sexual dysfunction after treatment for gynaecologic and breast malignancies. Curr Opin Obstet Gynecol 15:57-61, 2003
24. Nieboer P, Buijs C, Rodenhuis S, et al: Fatigue and relating factors in high-risk breast cancer patients with adjuvant standard- or high-dose chemotherapy: A longitudinal study. J Clin Oncol 23:8296-8304, 2005
25. Kornblith AB, Herndon JE, Weiss RB, et al: Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 98:679-689, 2003
26. Stanton AL, Bernaards CA, Ganz PA: The BCPT symptom scales: A measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst 97:448-456, 2005
27. Macquart-Moulin G, Viens P, Palangie T, et al: High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: Does impact on quality of life jeopardize feasibility and acceptability of treatment? J Clin Oncol 18:754-764, 2000